A Van Hoof

Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma

Berthe M.P. Aleman, John Raemaekers, Umberto Tirelli et al. · New England Journal of Medicine · 2003 · 306 citations · Full text

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias

Peter Vandenberghe, Lucienne Michaux, Pierre Zachée et al. · Leukemia · 2004 · 181 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +8

Double-Blind Trials with Ethamsylate, Batroxobin or Tranexamic Acid on Blood Loss After Adenotonsillectomy

Matthieu J. Verstraete, J Tyberghein, Yves De Greef et al. · Acta Clinica Belgica · 1977 · 30 citations

Double-blind Trials, Medicine, Perioperative Medicine +14

Controlled Trial of Suloctidil in Intermittent Claudication

Raymond Verhaeghe, A Van Hoof, G Beyens · Journal of Cardiovascular Pharmacology · 1981 · 25 citations

Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.

John Raemaekers, M Burgers, M. Henry‐Amar et al. · PubMed · 1997 · 23 citations